Published recalls only. Click View for full details and recall letter.
| SN | File / Recall No. | Medicine Name | Manufacturer | Batch No. | Recall Level | Class | Quality/Safety Issue | Date of Recall | Details |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ref.No.:DD/PVCT/4261/FDA/2025 |
Povimax 10% (all volumes, all batches)
|
Scott Edil Pharmacia Limited, India
|
ALL BATCHES | Retail | Class I |
contains Alphox 200 (prohibited ingredient)
|
18/11/2025 | |
| 2 | Ref No 009/RMS/CEO/2025 |
Omiren (Omeprazole Capsules BP 20 mg) BN: 00124 exp. 3/2026
|
RENE INDUSTRIES LTD, Kampala/ Uganda
|
BN: 00124 exp. 3/2026 | Retail | Class I |
failed to comply with dissolution test specifications
|
03/01/2025 | |
| 3 | Ref.No.: DD/PVCT/1720/FDA/2024 |
Benylin Pediatrics Syrup BN:329304, Mfd: May 2021,Exp:April 2024
|
Johnson & Johnson, South Africa
|
329304 | Consumer | Class I |
Unacceptable high level of diethylene glycol
|
12/04/2024 | |
| 4 | Ref No.:FDISM/PVSM/4190/FDA/2023 |
Misoprostol tablet 200mcg BN: all, Exp: all
|
Angel Biogenics Private Ltd/ India
|
All batches | Retail | Class I |
Therapeutic ineffectiveness due to unacceptable lower level of active pharmaceutical ingredient (API) ( failed identification test and assay).
|
07/10/2023 | |
| 5 | Ref No.:FDISM/PVSM/3611/FDA/2022 |
Broncalene sp Enfants
|
MELISANA PHARMA
|
BN: All | Consumer | Class I |
Increased risk of anaphylactic reaction on curares products used during general anesthesia
|
16/09/2022 | |
| 6 | Ref.No.:FDISM/PVSM/3611/FDA/2022 |
Broncalene sp Adultes
|
MELISANA PHARMA
|
BN: All | Consumer | Class I |
Increased risk of anaphylactic reaction on curares products used during general anesthesia
|
16/09/2022 | |
| 7 | Ref No.: DIS/3261/FDA/2021 |
Losar-Denk 100 mg film Coated
|
DENK PHARMA
|
ALL BATCHES | Consumer | Class I |
Genotoxic impurity detected in API
|
07/10/2021 | |
| 8 | Ref No.: DIS/3261/FDA/2021 |
Losar-Denk 25 mg film Coated
|
DENK PHARMA
|
ALL BATCHES | Consumer | Class I |
Genotoxic impurity detected in API
|
07/10/2021 | |
| 9 | Ref No.: DIS/3261/FDA/2021 |
Losar-Denk 50 mg film Coated
|
DENK PHARMA
|
ALL BATCHES | Consumer | Class I |
Genotoxic impurity detected in API
|
07/10/2021 | |
| 10 | Ref No.: DIS/3261/FDA/2021 |
Colosar-Denk 50mg /12,5mg film coated tablet
|
DENK PHARMA
|
ALL BATCHES | Consumer | Class I |
Genotoxic impurity detected in API
|
07/10/2021 | |
| 11 | Ref No.: DIS/3261/FDA/2021 |
Colosar-Denk 100 mg /12,5mg film coated tablet
|
DENK PHARMA
|
ALL BATCHES | Consumer | Class I |
Genotoxic impurity detected in API
|
07/10/2021 | |
| 12 | DIS/1853/FDA/2021 |
Atropine injection,
|
Pharmax India Pvt.Ltd/India
|
BN:16222001,Mfd:05/2020,Exp date:04/2023 | Retail | Class I |
Presence of Particulate matters
|
25/05/2021 | |
| 13 | DIS/1853/FDA/2021 |
Furosemide injection 20mg/2ml,
|
Laborate Pharmaceuticals India
|
BN:JFDIE-001,Mfd:11/2019,Exp:10/2022 | Retail | Class I |
Presence of Particulate matters
|
25/05/2021 | |
| 14 | DIS/1853/FDA/2021 |
Hyoscine Butylbromide Injection BP 20mg/ml,
|
Centurion Healthcare Private Limited/601, Atlantis Heights, Sarabhai Compound, Vadi Wadi,Vadodara-390 007, Gujarat,INDIA
|
BN:3H20001,Mfd:07/2020,Exp:06/2022 | Retail | Class I |
Presence of Particulate matters in Vials and Piece of broken glass in the ampoule
|
25/05/2021 | |
| 15 | DIS/1853/FDA/2021 |
Phytomenadione Inj. BP 10mg/ml
|
SANJAR PHARMA LLP,Himatnagar-VijapurHighway,Dedhrota,Hitmatnagar-383 220, GUJARAT,INDIA
|
BN:SA20C008E,Mfd:03/2020,Exp:02/2022 | Retail | Class I |
Presence of Particulate matters in Vials
|
25/05/2021 | |
| 16 | Ref No137/RwandaFDA/2020 |
Debridat 4.8mg/ml granules for oral suspension,125ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3857,Exp.date:11/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 17 | Ref No137/RwandaFDA/2020 |
Debridat 4.8mg/ml granules for oral suspension,125ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3860,Exp.date:12/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 18 | Ref No137/RwandaFDA/2020 |
Debridat 4.8mg/ml granules for oral suspension,125ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3859,Exp.date:12/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 19 | Ref No137/RwandaFDA/2020 |
Debridat 4.8mg/ml granules for oral suspension,125ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN: 3858Exp.date:11/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 20 | Ref No137/RwandaFDA/2020 |
Debridat 4.8mg/ml granules for oral suspension,125ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3856,Exp.date:11/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 21 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3814,Exp.date:06/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 22 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3815,Exp.date:06/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 23 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3816,Exp.date:06/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 24 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3817,Exp.date:06/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 25 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3818,Exp.date:06/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 26 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3819,Exp.date:06/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 27 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3820,Exp.date:06/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 28 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3851,Exp.date:10/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 29 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3852,Exp.date:10/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 30 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3853,Exp.date:10/2020 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 31 | Ref No137/RwandaFDA/2020 |
Debridat 24mg/ml granules for oral suspension,250ml
|
FARMEA10,RUE BOUCHE THOMASZAC SUD D'ORGEMONT 49000 Angers
|
BN:3867,Exp.date:02/2021 | Retail | Class I |
Potential foreign materials in the products
|
29/01/2020 | |
| 32 | Ref No 1756/ Rwanda FDA/2019 |
Helicobacter Pylori Antibody test strip,
|
QINGDAO HIGHTOP BIOTECH CO.,LTD/CHINA
|
B.N HPB11303B, mfd date: HPB11303B, exp date: 03-2021 | Retail | Class I |
The rapid test were giving false positive results
|
18/12/2019 | |
| 33 | ref No. 1756/Rwanda FDA/2019 |
Helicobacter Pyroli rapid tests,
|
QINGDAO HIGHTOP BIOTECH CO. LT
|
BN: HPB11308, EXP :03/2020 | Retail | Class I |
There were many false positif
|
18/12/2019 | |
| 34 | Ref No 1243/RwandaFDA/2019 |
Ranitidine ( all Brand ,all batches)
|
all
|
all Brand ,all batches | Retail | Class I |
contain nitrosamine impurity classified as probable human carcinogen
|
11/10/2019 | |
| 35 | Ref.No.0638/Rwanda FDA/2019 |
Biperiden.HCl Sterop Tablets 2 mg
|
Lab. STEROP NV, Belgium
|
BN: 18B05 Exp date: 01/2023 | Retail | Class I |
The medicine was found with higher rate of impurities in Laboratory quality control tests
|
18/06/2019 | |
| 36 | Ref. No 0108/ Rwandafda/2019 |
Cynomax (misoprostol 200ug) MAXTAR
|
BIO-GENICS /India
|
B.N: M8TAB1801 (Exp: 4/2020) | Retail | Class I |
Suspected poor Quality (Assay at 40%)
|
13/02/2019 | |
| 37 | Ref. No 0108/ Rwandafda/2019 |
C-STOL (Misoprostol 200 ug) CORONA
|
Remedies Pvt Ltd/India
|
B.N: ERW-005, EXP: 2/2021 | Retail | Class I |
Suspected poor Quality (Assay at 40%)
|
13/02/2019 | |
| 38 |
ANIOS SPECIAL DJP SF 4X5L, B.N:B14316S
|
Laboratoires Anios
|
— | Retail | Class I |
The product was reported to be contaminated by a bacteria
|
— | ||
| 39 |
ANIOS SPECIAL DJP SF 4X5L, B.N:A24104S
|
Laboratoires Anios
|
— | Retail | Class I |
The product was reported to be contaminated by a bacteria
|
— |